I.Ceram SA - Asset Resilience Ratio
I.Ceram SA (ALICR) has an Asset Resilience Ratio of -1.61% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does I.Ceram SA carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how I.Ceram SA's Asset Resilience Ratio has changed over time. See I.Ceram SA shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down I.Ceram SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ALICR stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-62.19K | -1.61% |
| Total Liquid Assets | €-62.19K | -1.61% |
Asset Resilience Insights
- Limited Liquidity: I.Ceram SA maintains only -1.61% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
I.Ceram SA Industry Peers by Asset Resilience Ratio
Compare I.Ceram SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for I.Ceram SA (2016–2023)
The table below shows the annual Asset Resilience Ratio data for I.Ceram SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -1.61% | €-62.19K ≈ $-72.71K |
€3.87 Million ≈ $4.52 Million |
-1.61pp |
| 2022-12-31 | 0.00% | €-1.00 ≈ $-1.17 |
€5.03 Million ≈ $5.88 Million |
-- |
| 2021-12-31 | 0.00% | €0.00 ≈ $0.00 |
€5.42 Million ≈ $6.33 Million |
-- |
| 2020-12-31 | 0.00% | €1.00 ≈ $1.17 |
€5.71 Million ≈ $6.68 Million |
-- |
| 2019-12-31 | 0.00% | €0.00 ≈ $0.00 |
€6.60 Million ≈ $7.71 Million |
-- |
| 2018-12-31 | 0.00% | €0.00 ≈ $0.00 |
€9.56 Million ≈ $11.18 Million |
-- |
| 2017-12-31 | 34.50% | €3.31 Million ≈ $3.87 Million |
€9.59 Million ≈ $11.21 Million |
-1.06pp |
| 2016-12-31 | 35.57% | €3.99 Million ≈ $4.66 Million |
€11.22 Million ≈ $13.12 Million |
-- |
About I.Ceram SA
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was incorporated in 2005 and is headquartered in Limoges, France. I.CERAM SA is a subsidiary of Investissement Développement.